VEGF-A drives pathological angiogenesis in wet AMD primarily by binding to VEGF receptor 2 (VEGFR2) on endothelial cells, activating downstream pathways such as the PI3K/Akt, MAPK/ERK, and PLCγ pathways (Figure 4, part 2). This evidence concerns the gene VEGFA and wet macular degeneration.